Characterization of apolipoprotein E genetic variations in Taiwanese: assocation with coronary heart disease and plasma lipid levels

Apolipoprotein E (apoE, protein; <i>APOE</i>, gene) is important in lipoprotein metabolism. Three isoforms, apoE2 (Cys112 Cys158), apoE3 (Cys112 Arg158), and apoE4 (Arg112 Arg158), are present in the general population. This report investigates the frequency distribution of apoE isoforms and the association of <i>APOE</i> genotypes with plasma lipid profile and coronary heart disease (CHD) in a population of Taiwan. ApoE isoforms were determined genetically by polymerase chain reaction and <i>HhaI</i> restriction enzyme digestion in control and coronary heart disease (CHD) patients. Plasma lipid and lipoprotein concentrations were also determined. The control group exhibited frequencies of 84.6% <i>APOE3</i>, 7.9% <i>APOE4</i>, 7.5% <i>APOE2</i>, 70.6% <i>APOE3E3</i>, 14.4% <i>APOE3E4</i>, 13.6% <i>APOE2E3</i>, and 1.4% <i>APOE2E4</i>. Comparable frequencies were observed in the CHD group. In both <i>APOE2</i> carrier and <i>APOE3E3</i> groups, the CHD patients expressed abnormal lipid profiles while the control group expressed normal lipid profiles. The <i>APOE4</i> carriers, however, expressed abnormal lipid profiles in both normal control and CHD groups. Extremely high apoE levels in the hypertriglyceridemic group (TG > 400 mg/dL) seemed to be undesirable and were often observed in CHD patients <br />